logo-loader

Motif Bio PLC

Receive alerts
Market:
AIM
Market Cap:
£1.06 m
Price
0.22 GBX
Change
-12.80%
52 weeks high
44.90
52 weeks low
0.22

In brief

Motif Bio is a clinical-stage biopharmaceutical company focused on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant Gram-positive bacteria, including MRSA.

Deep dive We explore the investor case for growth companies

Snapshot

Motif is confident there is a path to market for iclaprim, it will require a company with deeper pockets to take the putative treatment further.

Insight Widest with the analysis, Proactive gives perspectives that others don't.

If you want to hit it big (or fail spectacularly), speculate in resource stocks and biotechs

One has to kiss a lot of frogs before one finds oneself puckering up to a prince

2 weeks, 6 days ago